Floatz logo

E. Coli Cd-Expressing Genetically Modified Neural Stem Cells

Adult Anaplastic Oligodendroglioma

City of Hope Medical CenterCell therapyPhase 1Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Adult Anaplastic Oligodendroglioma cohort.

Asset / SponsorPhaseRating
Cediranib
National Cancer Institute (NCI)
Phase 2BBB
Irinotecan
City of Hope Medical Center
Phase 2BB
gsk1120212
Novartis Pharmaceuticals
Phase 4BB
Carboplatin
Oliver Jonas
Phase 2BB
CARMUSTINE
Shandong Lanjin Pharmaceuticals Co.,Ltd
Phase 3BB

View all 50 →

Same molecule, other indications

E. Coli Cd-Expressing Genetically Modified Neural Stem Cells is also rated in:

anaplastic astrocytomaDormant
CCC
Indicative ·
52 / 100
View asset →
giant cell glioblastomaDormant
CCC
Indicative ·
52 / 100
View asset →
adult glioblastomaDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →